[Therapeutic choice for the chronic myeloid leukemia patients in chronic phase showing late suboptimal response to imatinib].

Itaru Matsumura, Yasuhito Nannya, Tadashi Nagai, Kazuki Tanimoto, Kazuhisa Fujikawa, Masanobu Kasai, Yoko Inaguma, Makoto Takeuchi, Hiromasa Niimi, Hirokazu Kashiwagi, Yutaka Imamura, Toshinari Yagi, Erina Sakamoto, Masahiro Okabe, G. Aoki, Takuji Katayama, Masaya Okada, Yoko Adachi, Yoshio Saburi, Masahiro Kizaki